bms 180448 has been researched along with methoxamine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, WS; Lee, BH; Lee, CS; Lee, SH; Lim, JH; Seo, HW; Shin, HS; Won, HS; Yang, MK; Yi, KY; Yoo, SE | 1 |
1 other study(ies) available for bms 180448 and methoxamine
Article | Year |
---|---|
KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Topics: Animals; Aorta; Benzopyrans; Cardiotonic Agents; Decanoic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Glyburide; Guanidines; Heart Rate; Hydroxy Acids; Indoles; KATP Channels; L-Lactate Dehydrogenase; Male; Membrane Transport Modulators; Methoxamine; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Sarcolemma; Vasoconstrictor Agents; Vasodilation; Ventricular Function, Left; Ventricular Pressure | 2008 |